Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Fluicell | FLUI | 15. mai 2024 | 0.09 | -2.75 |
Gabather | GABA | 15. mai 2024 | 2.11 | -3.21 |
Genovis | GENO | 15. mai 2024 | 31.95 | +9.61 |
Glycorex Transplantati.. | GTABB | 15. mai 2024 | 0.98 | -1.41 |
Guard Therapeutics International | GUARD | 15. mai 2024 | 39.00 | +1.56 |
Hamlet BioPharma AB (publ) | HAMLETB | 15. mai 2024 | 4.20 | +3.19 |
Hansa Biopharma | HNSA | 15. mai 2024 | 38.00 | +1.33 |
Hemply Balance | HMPLY | 15. mai 2024 | 0.03 | -14.29 |
I-tech | ITECH | 15. mai 2024 | 48.20 | -0.21 |
Immunovia | IMMNOV | 15. mai 2024 | 1.55 | +1.84 |
InDex Pharmaceuticals Holding | INDEX | 15. mai 2024 | 0.41 | +1.22 |
Infant Bacterial Therapeutics B | IBTB | 15. mai 2024 | 97.80 | -1.21 |
Initiator Pharma | INIT | 15. mai 2024 | 9.30 | -0.64 |
Intervacc | IVACC | 15. mai 2024 | 4.37 | -7.02 |
IRLAB Therapeutics A | IRLABA | 15. mai 2024 | 15.75 | -2.78 |
Isofol Medical | ISOFOL | 15. mai 2024 | 0.70 | +0.14 |
Kancera | KAN | 15. mai 2024 | 1.67 | -7.00 |
Klaria Pharma Holding | KLAR | 15. mai 2024 | 0.37 | -18.14 |
LIDDS | LIDDS | 15. mai 2024 | 0.17 | +2.48 |
Lipidor | LIPI | 15. mai 2024 | 0.23 | +4.44 |
Lipigon Pharmaceuticals | LPGO | 15. mai 2024 | 0.29 | 0.00 |
Lipum | LIPUM | 15. mai 2024 | 6.70 | -2.19 |
Lumito | LUMITO | 15. mai 2024 | 1.20 | +0.84 |
Magle Chemoswed | MAGLE | 15. mai 2024 | 32.40 | 0.00 |
Medivir | MVIR | 15. mai 2024 | 2.92 | +0.34 |
Mendus AB | IMMU | 15. mai 2024 | 0.45 | -4.89 |
Miris Holding | MIR | 15. mai 2024 | 0.16 | -4.32 |
Moberg Pharma | MOB | 15. mai 2024 | 26.42 | -5.78 |
Modus Therapeutics | MODTX | 15. mai 2024 | 1.01 | -1.46 |
Nanexa | NANEXA | 15. mai 2024 | 0.92 | +9.03 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.